Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysis.
Jonathan CanaaniE BeohouM LabopinA GhavamzadehD BeelenR-M HamladjiD NiederwieserL VolinM MarkiewiczR ArnoldG MuftiG EhningerG SociéN KrögerM MohtyA NaglerPublished in: Journal of internal medicine (2018)
Outcome of allo-SCT for AML patients has markedly improved in the last two decades owing to decreased nonrelapse mortality and improved rates of leukaemia-free survival resulting in significantly longer survival.
Keyphrases
- stem cell transplantation
- free survival
- high dose
- end stage renal disease
- acute myeloid leukemia
- ejection fraction
- bone marrow
- newly diagnosed
- chronic kidney disease
- liver failure
- type diabetes
- risk factors
- acute lymphoblastic leukemia
- cardiovascular disease
- coronary artery disease
- aortic dissection
- allogeneic hematopoietic stem cell transplantation
- acute respiratory distress syndrome
- mechanical ventilation
- data analysis